Clinical Trials Sponsored by Millendo Therapeutics SAS
Total 95 results
-
Millendo Therapeutics SASTerminatedHyperphagia | Prader-Willi SyndromeUnited States, Belgium, Spain, France, Italy, United Kingdom, Australia, Netherlands
-
Millendo Therapeutics US, Inc.TerminatedCongenital Adrenal HyperplasiaSpain, Israel, France, Brazil, Czechia
-
Millendo Therapeutics US, Inc.TerminatedCushing SyndromeUnited States, United Kingdom
-
Millendo Therapeutics, Inc.CompletedCongenital Adrenal HyperplasiaUnited States
-
Millendo Therapeutics, Inc.CompletedAdrenocortical Carcinoma | Adrenal Cancer | ACCUnited States, Germany
-
Millendo Therapeutics US, Inc.Covance; Medpace, Inc.Terminated
-
Vivet Therapeutics SASRecruitingWilson's DiseaseUnited States, Denmark, Germany, United Kingdom
-
Amicus Therapeutics France SASActive, not recruitingFabry Disease | Anderson Fabry DiseaseFrance
-
Amicus Therapeutics France SASActive, not recruiting
-
Ryvu Therapeutics SARecruitingAcute Myeloid LeukemiaItaly, Poland
-
Ryvu Therapeutics SAActive, not recruitingAcute Myeloid Leukemia | High-risk Myelodysplastic SyndromeUnited States, Poland
-
Cerenis Therapeutics, SATerminatedFamilial HypoalphalipoproteinemiaFrance, United States, Belgium, Canada, Israel, Italy, Netherlands
-
Cerenis Therapeutics, SACompletedHomozygous Familial HypercholesterolemiaUnited States, Canada, Italy, Netherlands, United Kingdom
-
Cerenis Therapeutics, SACompletedAcute Coronary SyndromeCanada, United States, France, Netherlands
-
Ryvu Therapeutics SARecruitingAdvanced Solid TumorSpain, Poland
-
EXACT Therapeutics ASRecruitingColorectal Cancer | Solid TumorUnited Kingdom, Norway
-
Cerenis Therapeutics, SACompleted
-
SeneXta Therapeutics SACompleted
-
Ryvu Therapeutics SARecruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic SyndromePoland
-
Domain Therapeutics SARecruitingSolid Tumor, AdultFrance, Belgium
-
Nykode Therapeutics ASANektar Therapeutics; Vaccibody ASCompletedLocally Advanced or Metastatic Solid TumoursGermany
-
Orchard TherapeuticsOspedale San RaffaeleActive, not recruitingLysosomal Storage Diseases | Metachromatic LeukodystrophyItaly
-
Orchard TherapeuticsOspedale San RaffaeleActive, not recruitingLysosomal Storage Disease | Metachromatic LeukodystrophyItaly
-
Orchard TherapeuticsOspedale San RaffaeleActive, not recruitingLysosomal Storage Disease | Metachromatic LeukodystrophyItaly
-
Calliditas Therapeutics Suisse SAActive, not recruitingSquamous Cell Carcinoma of Head and NeckSpain, France, United States, Germany, Italy, Poland, United Kingdom
-
Calliditas Therapeutics Suisse SAActive, not recruitingPrimary Biliary Cholangitis | Liver StiffnessUnited States, Spain, France, Australia, Israel, Canada, Switzerland, Italy, New Zealand, Germany, Poland, Greece, United Kingdom, Belgium, Austria, Czechia, Hungary, Sweden
-
iTeos Belgium SARecruitingMetastatic NSCLC | Stage III NSCLCUnited States, Belgium, Spain, Switzerland, Italy, France, Canada, Poland, Czechia
-
Repare TherapeuticsDebiopharm International SARecruitingAdvanced Solid TumorUnited States, Canada, Denmark
-
Hubro Therapeutics ASQuotient SciencesCompleted
-
iTeos Belgium SACompleted
-
Nykode Therapeutics ASAVaccibody ASCompleted
-
IRCCS San RaffaeleOrchard Therapeutics; Fondazione TelethonUnknown
-
Proteon TherapeuticsUniversity of California, San FranciscoCompletedPeripheral Artery DiseaseUnited States
-
iTeos Belgium SAGlaxoSmithKline; iTeos TherapeuticsRecruitingMelanoma | Head and Neck Cancer | Lung Cancer | Advanced CancerSpain, Italy, France, United States, United Kingdom, Belgium
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaKorea, Republic of, United States, Belgium, Spain, Taiwan, China, United Kingdom, France, Canada, Germany, Thailand, Italy, Portugal, Australia, Puerto Rico
-
Nykode Therapeutics ASATheradex; Vaccibody ASCompletedHigh Grade Cervical Intraepithelial NeoplasiaGermany
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedUpper Tract Urothelial Carcinomas | Urothelial Bladder CancerUnited States, France, Canada, Spain, Italy, Belgium, Germany, Netherlands, United Kingdom, Bulgaria, Greece
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaUnited States, Belgium, Germany, Italy, Korea, Republic of, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Dr. Tapas K. Das GuptaCompletedRefractory Solid TumorsUnited States
-
Aardvark Therapeutics, Inc.University of California, San DiegoCompleted
-
University of California, San DiegoOncternal Therapeutics, IncActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Aardvark Therapeutics, Inc.University of California, San DiegoCompletedObesity | Weight Gain | Bariatric SurgeryUnited States
-
University of California, San FranciscoTobira Therapeutics, Inc.TerminatedHIV InfectionUnited States
-
Mast Therapeutics, Inc.University of California, San DiegoCompletedRectal Cancer | Colon CancerUnited States, Former Serbia and Montenegro
-
Atriva Therapeutics GmbHSGS Life Sciences, a division of SGS Belgium NVCompleted
-
Rhizen Pharmaceuticals SAIncozen Therapeutics Pvt LtdCompleted
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedSingle-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma MultiformeGlioblastoma MultiformeIsrael, United States
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedGlioblastomaUnited States, Israel, Canada
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedUlcerative ColitisPoland, Bulgaria, Hungary
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedPsoriasisGermany, Israel, Poland, Spain